Efficacy of vitamin D replacement therapy on patients with chronic nonspecific widespread musculoskeletal pain with vitamin D deficiency
dc.contributor.author | Yilmaz, Ramazan | |
dc.contributor.author | Salli, Ali | |
dc.contributor.author | Cingoz, Havva Turac | |
dc.contributor.author | Kucuksen, Sami | |
dc.contributor.author | Ugurlu, Hatice | |
dc.date.accessioned | 2024-02-23T14:24:00Z | |
dc.date.available | 2024-02-23T14:24:00Z | |
dc.date.issued | 2016 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Aim: The objective of this study is the evaluation of the effect of vitamin D replacement treatment on musculoskeletal symptoms and quality of life in patients with chronic widespread musculoskeletal pain (CWP) including fibromyalgia (FM) and vitamin D deficiency. Method: Patients with nonspecific CWP and vitamin D deficiency (25-OH D3<25ng/mL) were included into the study. Replacement treatments of 50000IU/week oral vitamin D3 for 3months were given to the patients. Patients were assessed pre- and post-treatment in terms of serum levels of Ca, P, alkaline phosphatase, 25-OH D3, severity of pain (visual analogue scale [VAS]-pain), severity of asthenia (VAS-asthenia), Beck Depression Inventory (BDI), quality of life scale (Short Form [SF]-36), tender point count (TPC), severity of waking unrefreshed, headache, tenderness on tibia, meeting the criteria of FM, and level of patient satisfaction. Results: Fifty-eight patients with a mean age of 36.9 +/- 9.2years were included into the study. 25-OH D3 levels of patients elevated from 10.6 +/- 5.1ng/mL to 46.5 +/- 24.0ng/mL after replacement treatment (P<0.001). Marked decrease in VAS-pain, VAS-asthenia, severity of waking unrefreshed, TPC, and BDI and an evident increase in subgroups of SF-36 were established in patients after treatment (P<0.001). The number of FM+ patients was 30 (52%) before treatment and regressed to 20 (34%) after treatment (P=0.013); 85% of patients stated satisfaction with the treatment. Conclusions: Vitamin D replacement treatment in patients with nonspecific CWP has provided improvements in musculoskeletal symptoms, level of depression and quality of life of patients. Patients with CWP should be investigated for vitamin D deficiency. | en_US |
dc.identifier.doi | 10.1111/1756-185X.12960 | |
dc.identifier.endpage | 1262 | en_US |
dc.identifier.issn | 1756-1841 | |
dc.identifier.issn | 1756-185X | |
dc.identifier.issue | 12 | en_US |
dc.identifier.pmid | 27860257 | en_US |
dc.identifier.scopus | 2-s2.0-85000605725 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1255 | en_US |
dc.identifier.uri | https://doi.org/10.1111/1756-185X.12960 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/13764 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | WOS:000398230800006 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | International Journal Of Rheumatic Diseases | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Chronic Pain | en_US |
dc.subject | Depression | en_US |
dc.subject | Fibromyalgia | en_US |
dc.subject | Quality Of Life | en_US |
dc.subject | Vitamin D Deficiency | en_US |
dc.title | Efficacy of vitamin D replacement therapy on patients with chronic nonspecific widespread musculoskeletal pain with vitamin D deficiency | en_US |
dc.type | Article | en_US |